ANTHONY LOCKABY: Open Payments
NPI 1467490334 · FORNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,706 in 117 payments from 30 companies in 2025. Trend: 2023 $936 · 2024 $2,438 · 2025 $3,706
Food & beverage: $3,706
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $426 |
| Novo Nordisk Inc | 17 | $420 |
| Otsuka America Pharmaceutical, Inc. | 7 | $360 |
| AstraZeneca Pharmaceuticals LP | 4 | $344 |
| PFIZER INC. | 10 | $292 |
| ABBVIE INC. | 13 | $281 |
| Axsome Therapeutics, Inc. | 3 | $220 |
| Lilly USA, LLC | 4 | $166 |
| Abbott Laboratories | 2 | $164 |
| Corcept Therapeutics | 3 | $153 |
Products named: REXULTI, Ozempic, REPATHA, AIRSUPRA, Auvelity, FREESTYLE LIBRE 3, VRAYLAR, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
